Source: Eur Respir J, 52 (5) 1802046; 10.1183/13993003.02046-2018
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Argyris Tzouvelekis, Paul J. Wolters. Pirfenidone in the kaleidoscope: reflecting mechanisms through different angles. Eur Respir J, 52 (5) 1802046; 10.1183/13993003.02046-2018

Member's Comments

No comment yet.

Related content which might interest you: Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy Source: Eur Respir J, 59 (2) 2102245; 10.1183/13993003.02245-2021 Year: 2022 Seeing the world through different lenses: activity registration differs between two validated accelerometers Source: ERJ Open Res, 6 (1) 00262-2019; 10.1183/23120541.00262-2019 Year: 2020 Breathe: new features and new ways to get involved Source: Breathe 2015; 11: 247-248 Year: 2015 Lumping: are the commonalities among fibrosing ILDs more important than the differences? Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis Year: 2019 Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - CON Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - PRO Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Lung hypertension: developmental mechanisms and assesment therapeutic action efficiency Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009 Producing documents for the ERS: types, requirements and processes Source: Annual Congress 2013 –How to produce top quality ERS Guidelines Year: 2013 Electrolyte disturbance: the effect of different forms of B-stimulants Source: Eur Respir J 2006; 28: Suppl. 50, 57s Year: 2006 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Marching to the beat of different drummers: individual airway response diversity Source: Eur Respir J 2004; 24: 193-194 Year: 2004 Asthma phenotypes: do metabolic pathways hold the key? Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink Year: 2017 The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation? Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases Year: 2019 Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage Source: Eur Respir J 2003; 22: Suppl. 45, 458s Year: 2003 A plethora of pathways, a medley of mediators: how do we tease out pathogenesis Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Bringing it all together: common pathways, emerging therapeutics and future directions Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease Year: 2014